View More Recent Stories

Dec 21, 2017 01:00PM FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma
Nov 28, 2017 08:10AM Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients with Pre-Treated Advanced Gastric Cancer
Nov 28, 2017 08:04AM Merck (MRK) and Pfizer (PFE) Announce Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer Did Not Meet Primary Endpoint
Nov 28, 2017 08:00AM Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer
Nov 7, 2017 04:00AM Merck's Consumer Health Leads Debate on Preparing Gen Z for 100 Healthy Years
Sep 21, 2017 06:23AM Merck KGaA, Pfizer (PFE) Report European Commission Approval for Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Sep 21, 2017 03:13AM European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Sep 11, 2017 06:57AM Merck KGaA, Darmstadt, Germany, Set to Join Forces with Project Data Sphere to Pioneer Global Oncology Big Data Alliance
View More Recent Stories